Mirabegron News
Mirabegron currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Mirabegron with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Overactive bladder in adults Betmiga prolonged-release tablets are indicated for symptomatic treatment of urgency, increased micturition frequency and/or urgency incontinence as may occur in...
- Evidence level: L5
- Predicted indications (20):
- overactive bladder (disease) (93.2%)
- thoracic malformation (83.1%)
- renal-hepatic-pancreatic dysplasia (82.9%)
- polycystic kidney disease 3 with or without polycystic liver disease (82.2%)
- Joubert syndrome with renal defect (80.9%)
- adult familial nephronophthisis-spastic quadriparesia syndrome (80.3%)
- esophageal varices without bleeding (80.0%)
- esophageal varices with bleeding (80.0%)
- hypotrichosis simplex of the scalp (79.5%)
- karyomegalic interstitial nephritis (79.2%)
- congenital hypotrichosis milia (77.5%)
- 16q24.1 microdeletion syndrome (75.2%)
- primary interstitial lung disease specific to childhood (74.2%)
- isolated pulmonary capillaritis (73.4%)
- low compliance bladder (73.2%)
- diffuse alopecia areata (71.4%)
- congenital pulmonary lymphangiectasia (67.8%)
- polycystic kidney disease (66.7%)
- varicose disease (64.3%)
- autosomal ichthyosis syndrome with fatal disease course (63.5%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.